Drug Information

Drug General Information
Drug ID
D0NF3E
Former ID
DNC005884
Drug Name
2-(4-nitro-1H-benzo[d]imidazol-2-yl)quinoxaline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527933]
Structure
Download
2D MOL

3D MOL
Formula
C15H9N5O2
Canonical SMILES
C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=CC=C4[N+](=O)[O-]
InChI
1S/C15H9N5O2/c21-20(22)13-7-3-6-11-14(13)19-15(18-11)12-8-16-9-4-1-2-5-10(9)17-12/h1-8H,(H,18,19)
InChIKey
RDSFCGCNTCJZOD-UHFFFAOYSA-N
PubChem Compound ID
11565524
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [527933]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.